By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vical Incorporated 

9373 Towne Centre Drive, Suite 100

San Diego  California  92121-3027  U.S.A.
Phone: 858-646-1100 Fax: 858-646-1150



Genzyme General 

Company News
Vical  (VICL) To Host Virtual Research & Development Day On May 2, 2017 4/24/2017 11:37:00 AM
Vical  (VICL) Completes Target Enrollment In Its Phase II Therapeutic HSV-2 Vaccine Trial 4/19/2017 8:35:20 AM
Astellas (ALPMY), Vical  (VICL)'s Experimental Herpes Vaccine Flunks Mid-Stage Test 9/19/2016 5:43:21 AM
Vical  (VICL) Reports First Quarter 2016 Financial Results 5/9/2016 10:26:19 AM
Vical  (VICL) To Present At The Stifel Healthcare Conference 2015 11/11/2015 10:13:42 AM
Vical  (VICL) Announces News Release And Conference Call Schedule For Third Quarter 2015 Financial Results 10/22/2015 8:15:47 AM
Vical  (VICL) To Present Preclinical Data At ICAAC 2015 Meeting For Its Novel Antifungal Drug Candidate VL-2397 9/15/2015 12:20:14 PM
Vical  (VICL) To Present At The Rodman & Renshaw 17th Annual Global Investment Conference 9/4/2015 7:18:55 AM
FDA Grants Qualified Infectious Disease Product (QIDP) Designation To VL-2397, Vical  (VICL)'s Antifungal Product Candidate 8/19/2015 7:23:34 AM
Vical  (VICL) Reports Second Quarter 2015 Financial Results And Progress In Key Development Programs 7/30/2015 8:04:11 AM